Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom.
Cobra venom, alone and in combination, on mast cell degranulation, histamine release and formation of prostaglandin-like activity (SRS-C) was studied in perfused guinea-pig lungs and in mast cell-containing rat peritoneal cell suspensions. For comparison, the effect of equivalent doses of whole cobra venom was investigated. 1. Cobra venom caused mast cell degranulation, histamine release and SRS-C formation in both systems. For comparable effects much higher doses had to be used in guine-pig lungs than in rat peritoneal cell suspensions. 2. Phase A showed little degranulation of mast cells in both systems, a limited histamine release in rat peritoneal cell suspensions and none in perfused guinea-pig lungs. It caused a considerable SRS-C formation in both, lung tissue and peritoneal cell suspensions. 3. DLF caused histamine release, SRS-C formation and mast cell degranulation in both systems; in rat peritoneal cell suspensions it acted almost as strong as equivalent doses of cobra venom, in guinea pig lungs it was much less active. 4. In rat peritoneal cell suspensions the effects of DLF and phase A in combination did not exceed the sum of their single effects. In guinea-pig lungs these two substances interacted in a potentiating synergism. It is concluded that DLF is the main cytotoxic principle of cobra venom, whereas ph-ase A alone is not cytotoxic. The difference in the synergism of DLF and ph-ase A between rat peritoneal cells and guinea-pig lungs may be due to two different actions of DLF and species differences as regards sensitivity against these actions.
D000818:Animals; D001202:Ascitic Fluid / Q000166:cytology; D012898:Autacoids / Q000378:metabolism*; D003594:Cytoplasmic Granules / Q000187:drug effects; D006168:Guinea Pigs; D006636:Histamine Release / Q000187:drug effects*; D008168:Lung / Q000187:drug effects; D008407:Mast Cells / Q000187:drug effects*; D010455:Peptides / Q000494:pharmacology*; D010740:Phospholipases / Q000494:pharmacology*; D051381:Rats; D012910:Snake Venoms / Q000494:pharmacology*; D014688:Venoms / Q000494:pharmacology*
D012898:Autacoids; D010455:Peptides; D012910:Snake Venoms; D014688:Venoms; D010740:Phospholipases